91 related articles for article (PubMed ID: 28551638)
1. Modulation of Melanotransferrin and Transferrin Receptor 1 (TFRC)- and CD44-based Signaling for TFRC Up-regulation in Human Melanoma Cells.
Laube F; Glanz D
Anticancer Res; 2017 Jun; 37(6):3001-3007. PubMed ID: 28551638
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronan-CD44 interaction with neural Wiskott-Aldrich syndrome protein (N-WASP) promotes actin polymerization and ErbB2 activation leading to beta-catenin nuclear translocation, transcriptional up-regulation, and cell migration in ovarian tumor cells.
Bourguignon LY; Peyrollier K; Gilad E; Brightman A
J Biol Chem; 2007 Jan; 282(2):1265-80. PubMed ID: 17092940
[TBL] [Abstract][Full Text] [Related]
3. The role of the membrane-bound tumour antigen, melanotransferrin (p97), in iron uptake by the human malignant melanoma cell.
Richardson DR
Eur J Biochem; 2000 Mar; 267(5):1290-8. PubMed ID: 10691965
[TBL] [Abstract][Full Text] [Related]
4. CD44 stimulation by fragmented hyaluronic acid induces upregulation of urokinase-type plasminogen activator and its receptor and subsequently facilitates invasion of human chondrosarcoma cells.
Kobayashi H; Suzuki M; Kanayama N; Nishida T; Takigawa M; Terao T
Int J Cancer; 2002 Dec; 102(4):379-89. PubMed ID: 12402308
[TBL] [Abstract][Full Text] [Related]
5. CD44 mediates oligosaccharides of hyaluronan-induced proliferation, tube formation and signal transduction in endothelial cells.
Wang YZ; Cao ML; Liu YW; He YQ; Yang CX; Gao F
Exp Biol Med (Maywood); 2011 Jan; 236(1):84-90. PubMed ID: 21239738
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid.
Ahrens T; Sleeman JP; Schempp CM; Howells N; Hofmann M; Ponta H; Herrlich P; Simon JC
Oncogene; 2001 Jun; 20(26):3399-408. PubMed ID: 11423990
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor-2 stimulates directed migration of periodontal ligament cells via PI3K/AKT signaling and CD44/hyaluronan interaction.
Shimabukuro Y; Terashima H; Takedachi M; Maeda K; Nakamura T; Sawada K; Kobashi M; Awata T; Oohara H; Kawahara T; Iwayama T; Hashikawa T; Yanagita M; Yamada S; Murakami S
J Cell Physiol; 2011 Mar; 226(3):809-21. PubMed ID: 20857427
[TBL] [Abstract][Full Text] [Related]
8. Identification of distinct changes in gene expression after modulation of melanoma tumor antigen p97 (melanotransferrin) in multiple models in vitro and in vivo.
Suryo Rahmanto Y; Dunn LL; Richardson DR
Carcinogenesis; 2007 Oct; 28(10):2172-83. PubMed ID: 17449903
[TBL] [Abstract][Full Text] [Related]
9. Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells.
Galluzzo E; Albi N; Fiorucci S; Merigiola C; Ruggeri L; Tosti A; Grossi CE; Velardi A
Eur J Immunol; 1995 Oct; 25(10):2932-9. PubMed ID: 7589094
[TBL] [Abstract][Full Text] [Related]
10. Chondrocytes are regulated by cellular adhesion through CD44 and hyaluronic acid pathway.
Ishida O; Tanaka Y; Morimoto I; Takigawa M; Eto S
J Bone Miner Res; 1997 Oct; 12(10):1657-63. PubMed ID: 9333126
[TBL] [Abstract][Full Text] [Related]
11. Coincident expression and distribution of melanotransferrin and transferrin receptor in human brain capillary endothelium.
Rothenberger S; Food MR; Gabathuler R; Kennard ML; Yamada T; Yasuhara O; McGeer PL; Jefferies WA
Brain Res; 1996 Mar; 712(1):117-21. PubMed ID: 8705293
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and spectroscopic studies of human melanotransferrin (MTf): electron-paramagnetic resonance evidence for a difference between the iron-binding site of MTf and other transferrins.
Farnaud S; Amini M; Rapisarda C; Cammack R; Bui T; Drake A; Evans RW; Suryo Rahmanto Y; Richardson DR
Int J Biochem Cell Biol; 2008; 40(12):2739-45. PubMed ID: 18691669
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer.
Wang SJ; Bourguignon LY
Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):771-8. PubMed ID: 16847188
[TBL] [Abstract][Full Text] [Related]
14. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronan increases RANKL expression in bone marrow stromal cells through CD44.
Cao JJ; Singleton PA; Majumdar S; Boudignon B; Burghardt A; Kurimoto P; Wronski TJ; Bourguignon LY; Halloran BP
J Bone Miner Res; 2005 Jan; 20(1):30-40. PubMed ID: 15619667
[TBL] [Abstract][Full Text] [Related]
16. Co-localization of CD44 and urokinase-type plasminogen activator on the surface of human melanoma cells.
Laube F
Anticancer Res; 2000; 20(6D):5045-8. PubMed ID: 11326665
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronan-CD44 interaction stimulates Rac1 signaling and PKN gamma kinase activation leading to cytoskeleton function and cell migration in astrocytes.
Bourguignon LY; Gilad E; Peyrollier K; Brightman A; Swanson RA
J Neurochem; 2007 May; 101(4):1002-17. PubMed ID: 17403031
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction.
Bourguignon LY; Lokeshwar VB; Chen X; Kerrick WG
J Immunol; 1993 Dec; 151(12):6634-44. PubMed ID: 7505012
[TBL] [Abstract][Full Text] [Related]
19. The melanoma tumor antigen, melanotransferrin (p97): a 25-year hallmark--from iron metabolism to tumorigenesis.
Suryo Rahmanto Y; Dunn LL; Richardson DR
Oncogene; 2007 Sep; 26(42):6113-24. PubMed ID: 17452986
[TBL] [Abstract][Full Text] [Related]
20. The influence of hyaluronan-CD44 interaction on topoisomerase II activity and etoposide cytotoxicity in head and neck cancer.
Wang SJ; Peyrollier K; Bourguignon LY
Arch Otolaryngol Head Neck Surg; 2007 Mar; 133(3):281-8. PubMed ID: 17372087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
